Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | LTA4H | P09960 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20286678 | 0.91 | CA2 (0.63) | CA2GAAALDH1A1 | |
| SCHEMBL2090122 | 0.89 | CA2 (0.57) | CA2LTA4HGAAALDH1A1 | |
| SCHEMBL27296853 | 0.86 | CA2 (0.53) | CA2GAALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL26857915 | 0.85 | CA2 (0.52) | CA2LTA4HGAAALDH1A1 | |
| SCHEMBL83495 | 0.82 | CA2 (0.80) | CA2LTA4HGAALMNAALDH1A1 | |
| SCHEMBL11950523 | 0.81 | CA2 (0.48) | CA2GAALMNASMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL4861530 | 0.80 | CA2 (0.77) | CA2LTA4HGAALMNAALDH1A1 | |
| SCHEMBL10061253 | 0.80 | SIGMAR1 (0.62) | LMNASMN1; SMN2 | |
| SCHEMBL11089774 | 0.80 | LMNA (0.52) | CA2LTA4HLMNA | |
| SCHEMBL9450898 | 0.79 | CA2 (0.57) | CA2LTA4HGAAALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9505878-B2 | Catalysts and methods for polymer synthesis | NOVOMER, INC. (US) | 2016-11-29 | — | — | US | disclosed |
| US-20160272761-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2016-09-22 | — | — | US | disclosed |
| US-20150252145-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2015-09-10 | — | — | US | disclosed |
| US-8946109-B2 | Catalysts and methods for polymer synthesis | NOVOMER, INC. (US) | 2015-02-03 | — | — | US | disclosed |
| US-8633123-B2 | Catalysts and methods for polymer synthesis | NOVOMER, INC. (US) | 2014-01-21 | — | — | US | disclosed |
| US-20130144032-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | NOVOMER, INC. (US) | 2013-06-06 | — | — | US | disclosed |
| EP-0057740-A1 | Pressure sensitive recording sheets | DIAMOND SHAMROCK CORPORATION (US) | 1982-08-18 | — | — | EP | disclosed |
| US-4275906-A | Pressure sensitive recording sheets | DIAMOND SHAMROCK CORPORATION (US) | 1981-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130144032-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | PPOX, COASY, SOD1 | CA2 90/4885LTA4H 409/4885GAA 668/4885 |
| US-20160272761-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | PPOX, COASY, SOD1 | CA2 90/4885LTA4H 409/4885GAA 668/4885 |
| US-20150252145-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | PPOX, COASY, SOD1 | CA2 90/4885LTA4H 409/4885GAA 668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.